WO2008036801A3 - Methods and systems of delivering medication via inhalation - Google Patents

Methods and systems of delivering medication via inhalation Download PDF

Info

Publication number
WO2008036801A3
WO2008036801A3 PCT/US2007/078999 US2007078999W WO2008036801A3 WO 2008036801 A3 WO2008036801 A3 WO 2008036801A3 US 2007078999 W US2007078999 W US 2007078999W WO 2008036801 A3 WO2008036801 A3 WO 2008036801A3
Authority
WO
WIPO (PCT)
Prior art keywords
systems
methods
via inhalation
delivering medication
medication via
Prior art date
Application number
PCT/US2007/078999
Other languages
French (fr)
Other versions
WO2008036801A2 (en
Inventor
Edward Lemahieu
Charles Jones
Tom Stern
Jack Hebrank
Charles Eric Hunter
Lyndell Duvall
Chris Hartley
Bernard L Ballou
Jocelyn Hunter
Laurie Mcneil
Paul Wetzel
Ron Criss
Original Assignee
Next Safety Inc
Edward Lemahieu
Charles Jones
Tom Stern
Jack Hebrank
Charles Eric Hunter
Lyndell Duvall
Chris Hartley
Bernard L Ballou
Jocelyn Hunter
Laurie Mcneil
Paul Wetzel
Ron Criss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/552,871 external-priority patent/US20080078382A1/en
Application filed by Next Safety Inc, Edward Lemahieu, Charles Jones, Tom Stern, Jack Hebrank, Charles Eric Hunter, Lyndell Duvall, Chris Hartley, Bernard L Ballou, Jocelyn Hunter, Laurie Mcneil, Paul Wetzel, Ron Criss filed Critical Next Safety Inc
Priority to JP2009529388A priority Critical patent/JP2010504171A/en
Priority to CA002662777A priority patent/CA2662777A1/en
Publication of WO2008036801A2 publication Critical patent/WO2008036801A2/en
Publication of WO2008036801A3 publication Critical patent/WO2008036801A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/001—Details of inhalators; Constructional features thereof with means for agitating the medicament using ultrasonic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A61M16/0066—Blowers or centrifugal pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A61M16/0066—Blowers or centrifugal pumps
    • A61M16/0069—Blowers or centrifugal pumps the speed thereof being controlled by respiratory parameters, e.g. by inhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
    • A61M16/109—Preparation of respiratory gases or vapours by influencing the temperature the humidifying liquid or the beneficial agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A61M16/16—Devices to humidify the respiration air
    • A61M16/161—Devices to humidify the respiration air with means for measuring the humidity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/008—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/047—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters by exothermic chemical reaction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A61M15/025—Bubble jet droplet ejection devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0051—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A61M16/024—Control means therefor including calculation means, e.g. using a processor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6054—Magnetic identification systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6063—Optical identification systems
    • A61M2205/6072—Bar codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8206—Internal energy supply devices battery-operated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A61M2230/06—Heartbeat rate only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/30—Blood pressure

Abstract

Systems and methods for delivery of a drug to the respiratory system of a patient where the drug is supplied at a positive pressure relative to atmospheric pressure are provided. In particular, the drugs are delivered to the respiratory system of a patient who is capable of unassisted breathing. With the systems and methods of the present disclosure, medication available in a variety of forms is introduced in a controlled fashion into the air stream in aerosol, nebulized, or vaporized form.
PCT/US2007/078999 2006-09-20 2007-09-20 Methods and systems of delivering medication via inhalation WO2008036801A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009529388A JP2010504171A (en) 2006-09-20 2007-09-20 Method and system for drug delivery through inhalation
CA002662777A CA2662777A1 (en) 2006-09-20 2007-09-20 Methods and systems of delivering medication via inhalation

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US82627106P 2006-09-20 2006-09-20
US60/826,271 2006-09-20
US11/552,871 2006-10-25
US11/552,871 US20080078382A1 (en) 2006-09-20 2006-10-25 Methods and Systems of Delivering Medication Via Inhalation
US11/627,692 2007-01-26
US11/627,692 US20080066739A1 (en) 2006-09-20 2007-01-26 Methods and systems of delivering medication via inhalation

Publications (2)

Publication Number Publication Date
WO2008036801A2 WO2008036801A2 (en) 2008-03-27
WO2008036801A3 true WO2008036801A3 (en) 2008-07-31

Family

ID=38819750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/078999 WO2008036801A2 (en) 2006-09-20 2007-09-20 Methods and systems of delivering medication via inhalation

Country Status (5)

Country Link
US (2) US20080066739A1 (en)
EP (2) EP1902742A1 (en)
JP (1) JP2010504171A (en)
CA (1) CA2662777A1 (en)
WO (1) WO2008036801A2 (en)

Families Citing this family (199)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
US7678386B2 (en) 2002-07-15 2010-03-16 Board Of Regents The University Of Texas Liposomes coated with selected antibodies that bind to aminophospholipids
US7378386B2 (en) 2002-07-15 2008-05-27 Board Of Regents, The University Of Texas System Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
US8156937B2 (en) * 2003-08-04 2012-04-17 Carefusion 203, Inc. Portable ventilator system
BRPI0413275A (en) * 2003-08-04 2006-10-10 Pulmonetic Systems Inc portable fan and portable fan system
US8118024B2 (en) 2003-08-04 2012-02-21 Carefusion 203, Inc. Mechanical ventilation system utilizing bias valve
US7607437B2 (en) * 2003-08-04 2009-10-27 Cardinal Health 203, Inc. Compressor control system and method for a portable ventilator
US7527053B2 (en) * 2003-08-04 2009-05-05 Cardinal Health 203, Inc. Method and apparatus for attenuating compressor noise
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US9022027B2 (en) 2004-02-20 2015-05-05 Pneumoflex Systems, Llc Nebulizer with intra-oral vibrating mesh
CN101010305B (en) 2004-08-20 2010-08-11 曼金德公司 Catalysis of diketopiperazine synthesis
PL2322180T3 (en) 2004-08-23 2015-10-30 Mannkind Corp Diketopiperazine salts for drug delivery
US20090280064A1 (en) * 2005-06-24 2009-11-12 Rao Papineni Transdermal delivery of optical, spect, multimodal, drug or biological cargo laden nanoparticle(s) in small animals or humans
CN104324362B (en) 2005-09-14 2018-04-24 曼金德公司 Method for preparation of drug based on improving affinity of the active agent to crystalline microparticle surfaces
CN104383546B (en) 2006-02-22 2021-03-02 曼金德公司 Method for improving the pharmaceutical properties of microparticles comprising diketopiperazines and an active agent
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
KR100816065B1 (en) * 2006-11-27 2008-03-24 동국제약 주식회사 Preparation method of sustained-release microcapsules having good initial burst inhibiting property and the microcapsules thereby
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US20090065007A1 (en) 2007-09-06 2009-03-12 Wilkinson William R Oxygen concentrator apparatus and method
AU2008310734B2 (en) 2007-10-10 2014-06-05 Parion Sciences, Inc. Delivering osmolytes by nasal cannula
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
US7997885B2 (en) * 2007-12-03 2011-08-16 Carefusion 303, Inc. Roots-type blower reduced acoustic signature method and apparatus
US8888711B2 (en) * 2008-04-08 2014-11-18 Carefusion 203, Inc. Flow sensor
EA022565B1 (en) * 2008-05-27 2016-01-29 Дзе Юниверсити Оф Мельбурн Methods of treating mammals with eustachian tube dysfunctions
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
KR101628410B1 (en) 2008-06-20 2016-06-08 맨카인드 코포레이션 An interactive apparatus and method for real-time profiling of inhalation efforts
TWI494123B (en) 2008-08-11 2015-08-01 Mannkind Corp Use of ultrarapid acting insulin
JP5827123B2 (en) * 2008-09-16 2015-12-02 ウェルズ ファーゴ バンク ナショナル アソシエイション PEGylated opioids with low potential for abuse
WO2010036973A1 (en) * 2008-09-25 2010-04-01 Comgenrx, Inc. Treatment of hyperproliferative disorders using cardiac glycosides
WO2010045408A2 (en) * 2008-10-16 2010-04-22 The Cooper Health System Automated delivery of aerosolized drugs during anesthesia with synchronized ventilation
US8168597B2 (en) * 2008-10-22 2012-05-01 Inspire Pharmaceuticals, Inc. Method for treating cystic fibrosis
EP2179760B1 (en) 2008-10-22 2013-02-27 Trudell Medical International Modular Aerosol Delivery System
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US20110232636A1 (en) * 2008-12-18 2011-09-29 Koninklijke Philips Electronics, N.V. Valved holding chamber and mask therefor
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9750903B2 (en) 2008-12-30 2017-09-05 Gearbox, Llc Method for administering an inhalable compound
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
WO2010088548A1 (en) 2009-01-29 2010-08-05 Forsight Labs, Llc Posterior segment drug delivery
WO2010099000A2 (en) * 2009-02-24 2010-09-02 Teva Medical Ltd. Vial adapter assembly in drug mixing system
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp DEVICE, SYSTEM AND PROCEDURE FOR MEASURING RESISTANCE IN AN INHALATOR
US8083938B2 (en) 2009-05-06 2011-12-27 Baldwin Filters, Inc. Filter end cap assembly with bypass valve
RU2636614C2 (en) * 2009-05-19 2017-11-24 Вивия Байотек С.Л. Methods for personalized medical testing ex vivo for hematological neoplasms
BRPI1013154B1 (en) 2009-06-12 2020-04-07 Mannkind Corp MICROPARTICLES OF DICETOPIPERAZINE WITH SPECIFIC SURFACE AREAS DEFINED, DRY POWDER UNDERSTANDING THE REFERRED MICROPARTICLES, METHOD FOR FORMATION OF THE REFERENCESMICROPARTICLES AND THE FORMATION OF MICROPARTYSTEMS
PL2326332T3 (en) 2009-06-22 2013-05-31 Ampio Pharmaceuticals Inc Method for treatment of diseases
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
CA3031481C (en) * 2009-07-10 2021-03-16 Linzy O. Scott, Iii Methods and compositions for treating thyroid-related medical conditions with reduced folates
US7947653B1 (en) 2009-10-09 2011-05-24 Cold Spring Harbor Laboratory Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers
US8323883B1 (en) 2009-10-09 2012-12-04 Cold Spring Harbor Laboratory Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors
US8623329B1 (en) * 2009-10-13 2014-01-07 Aerophase, Inc. Method for the treatment of lung tumors
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
BR112012023877A2 (en) * 2010-03-15 2016-08-02 Univ Virginia Commonwealth aerosolized dapsone as a therapy for airway inflammation and abnormal mucociliary transport
CN106038574A (en) * 2010-04-15 2016-10-26 拜耳知识产权有限责任公司 Low-dosed solid oral dosage forms for HRT
US8695591B2 (en) * 2010-05-26 2014-04-15 Lloyd Verner Olson Apparatus and method of monitoring and responding to respiratory depression
US9492315B2 (en) 2010-08-05 2016-11-15 Forsight Vision4, Inc. Implantable therapeutic device
US10617557B2 (en) 2010-08-05 2020-04-14 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
RS61601B1 (en) 2010-08-05 2021-04-29 Forsight Vision4 Inc Injector apparatus for drug delivery
CN102370984B (en) * 2010-08-18 2015-04-08 天津金耀集团有限公司 Inhalation medicinal composition prepared from eplerenone and glucocorticoid serving as active ingredients
CN103328028B (en) 2010-08-24 2016-10-26 特鲁德尔医学国际公司 aerosol delivery device
US8603228B2 (en) * 2010-09-07 2013-12-10 Inova Labs, Inc. Power management systems and methods for use in an oxygen concentrator
CN102416179B (en) 2010-09-28 2014-05-07 益得生物科技股份有限公司 Inhaled compound composition for asthma
US20140031769A1 (en) 2010-11-19 2014-01-30 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
JP2014503593A (en) 2011-01-28 2014-02-13 ファンタスティック・メディカル・リサーチ・インスティテュート・エルエルシー Method for treating obstructive sleep apnea
RU2612506C2 (en) * 2011-03-03 2017-03-09 Импел Ньюрофарма Инк. Nasal drug delivery device
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012142190A1 (en) * 2011-04-11 2012-10-18 Visionary Road Portable vaporizer
US9452212B2 (en) * 2011-04-14 2016-09-27 Dynavax Technologies Corporation Methods and compositions for eliciting an immune response against hepatitis B virus
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
JP6219271B2 (en) 2011-06-07 2017-10-25 パリオン・サイエンシィズ・インコーポレーテッド Method of treatment
GB201110058D0 (en) * 2011-06-15 2011-07-27 3M Innovative Properties Co Medicinal inhalation devices, valves and components thereof
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2726016B1 (en) 2011-06-28 2023-07-19 ForSight Vision4, Inc. An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
EP2739252A4 (en) 2011-08-05 2015-08-12 Forsight Vision4 Inc Small molecule delivery with implantable therapeutic device
RS61758B1 (en) 2011-09-16 2021-05-31 Forsight Vision4 Inc Fluid exchange apparatus
CN103857398A (en) * 2011-10-07 2014-06-11 安皮奥制药股份有限公司 Treatment of rhinitis
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
BR112014013734A8 (en) 2011-12-06 2017-06-13 Masco Corp ozone distribution on a tap
WO2013112865A1 (en) * 2012-01-27 2013-08-01 The Trustees Of The University Of Pennsylvania Diagnosis and treatment for respiratory tract diseases
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US20150038719A1 (en) * 2012-03-14 2015-02-05 Ltt Bio-Pharma Co., Ltd. Agent for Ameliorating Chronic Obstructive Pulmonary Disease
GB2500588B (en) 2012-03-24 2017-02-01 Rhinocare Ltd Systems and methods of hyperthermal treatment
CN103371969A (en) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 Metaraminol bitartrate injection and preparation technology thereof
US9272036B2 (en) 2012-04-18 2016-03-01 Clover Hill Healthcare, Inc. Carbon dioxide, saline and additional active nasal delivery methods and treatments
CA3176217A1 (en) 2012-04-27 2013-10-31 Fisher & Paykel Healthcare Limited Usability features for respiratory humidification system
US10052464B2 (en) 2012-06-04 2018-08-21 Clover Hill Healthcare, Inc. Low flow rate nasal treatment delivery device for mixed carbon dioxide and saline
US9370632B2 (en) 2012-06-04 2016-06-21 Clover Hill Healthcare, Inc. Nasal treatment delivery device for mixed carbon dioxide and saline
CN108057154B (en) 2012-07-12 2021-04-16 曼金德公司 Dry powder drug delivery system and method
US10507294B2 (en) * 2012-08-13 2019-12-17 Koninklijke Philips N.V. Handheld dyspnea treatment device with drug and gas delivery
WO2014059408A1 (en) 2012-10-12 2014-04-17 Inova Labs, Inc. Dual oxygen concentrator systems and methods
WO2014059405A1 (en) 2012-10-12 2014-04-17 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
AU2013328916A1 (en) 2012-10-12 2015-05-14 Inova Labs, Inc. Oxygen concentrator systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
US8545878B1 (en) * 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use
ES2622372T3 (en) 2012-11-09 2017-07-06 Scidose Llc Enema composition for treatment of ulcerative colitis that has long-term stability
BR112015010601B1 (en) 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
US9351979B2 (en) 2012-12-19 2016-05-31 Ampio Pharmaceuticals, Inc. Methods of treatment of diseases
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
RU2015132569A (en) 2013-01-11 2017-02-14 Кселлия Фармасьютикалз Апс POLYMIXINS, COMPOSITIONS WITH THEM, METHODS FOR PRODUCING AND METHODS OF APPLICATION
EP2968113B8 (en) 2013-03-14 2020-10-28 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
ES2928365T3 (en) 2013-03-15 2022-11-17 Mannkind Corp Microcrystalline diketopiperazine compositions, methods of preparation and use thereof
CA2907681C (en) 2013-03-28 2022-11-22 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
EP3607941A1 (en) 2013-04-30 2020-02-12 Otitopic Inc. Dry powder formulations and methods of use
ITRM20130309A1 (en) * 2013-05-29 2014-11-30 Ohg Galli Srl "ANTIAEROSOL FILTERING ELEMENT FOR NBC MASKS WITH ANTIMICROBIAL ACTIVITY"
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
CA3172586A1 (en) * 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
CN105517607A (en) 2013-08-05 2016-04-20 曼金德公司 Insufflation apparatus and methods
JP6663850B2 (en) * 2013-09-13 2020-03-13 フィッシャー アンド ペイケル ヘルスケア リミテッド Humidification system connection
US10758700B2 (en) * 2013-09-30 2020-09-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Home-based heliox system with carbon dioxide removal
US20150114388A1 (en) * 2013-10-28 2015-04-30 Alfredo R. Fernandez Adapter for an anesthesia face mask
HUE032205T2 (en) 2013-11-08 2017-09-28 Lilly Co Eli Atomoxetine solution
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
WO2015095644A1 (en) 2013-12-20 2015-06-25 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
WO2015119515A1 (en) 2014-02-07 2015-08-13 Fisher & Paykel Healthcare Limited Respiratory humidification system
US9440179B2 (en) 2014-02-14 2016-09-13 InovaLabs, LLC Oxygen concentrator pump systems and methods
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106102748A (en) 2014-02-20 2016-11-09 奥迪托皮克股份有限公司 For the dry powder formulations sucked
TWI589308B (en) * 2014-03-25 2017-07-01 林信湧 Inhalation-type pharmaceutical composition for parkinson's disease and preparation method thereof
TWI590837B (en) * 2014-03-25 2017-07-11 林信湧 Inhalation-type pharmaceutical composition for heart disease and preparation method thereof
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
TWI569816B (en) * 2014-04-18 2017-02-11 林信湧 Inhalation-type pharmaceutical composition for gout and preparation method thereof
TWI594772B (en) * 2014-04-18 2017-08-11 林信湧 Inhalation-type pharmaceutical composition for hypertension and preparation method thereof
TWI586382B (en) * 2014-04-18 2017-06-11 林信湧 Inhalation-type pharmaceutical composition for kidney disease and preparation method thereof
CN106535971B (en) 2014-06-03 2020-12-04 费雪派克医疗保健有限公司 Flow mixer for respiratory therapy system
US20170189727A1 (en) * 2014-06-04 2017-07-06 Free Air, Inc. Systems and methods for removing ultra-fine particles from air
BR112017000228A2 (en) 2014-07-09 2017-10-31 Xellia Pharmaceuticals Aps low substitution polymyxins and their compositions.
RU2695563C2 (en) 2014-07-15 2019-07-24 Форсайт Вижн4, Инк. Method and device for eye implant delivery
US11413408B2 (en) 2014-07-29 2022-08-16 Peter Edenhoffer Positive pressure inspiration device for delivery of medicaments
CA2956447C (en) * 2014-07-29 2023-04-11 Peter EDENHOFFER Positive pressure inspiration device for delivery of medicaments
WO2016022750A1 (en) 2014-08-08 2016-02-11 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
GB201414820D0 (en) 2014-08-20 2014-10-01 Brown Sebastian M Improvements to anaesthetic recycling methods and systems
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
SI3200827T1 (en) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Compositions
RU2702335C2 (en) * 2014-10-03 2019-10-08 Кселлия Фармасьютикалз Апс Inhalation device
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
JP7037360B2 (en) 2014-11-10 2022-03-16 フォーサイト・ビジョン フォー・インコーポレーテッド Expandable drug delivery device
US20160158471A1 (en) * 2014-12-05 2016-06-09 Dance Biopharm, Inc. Integration of glucose data to adjust inhaled insulin dose
US10736357B2 (en) * 2014-12-25 2020-08-11 Fontem Holdings 1 B.V. Electronic cigarette liquid detection and measurement systems
US11247015B2 (en) 2015-03-24 2022-02-15 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
US10315002B2 (en) 2015-03-24 2019-06-11 Ventec Life Systems, Inc. Ventilator with integrated oxygen production
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery
US20180154103A1 (en) * 2015-05-22 2018-06-07 Compressed Perforated Puck Technologies Inc. Vaporizer apparatus for compressed tablet and loose fill plant source materials
US10046007B2 (en) 2015-06-24 2018-08-14 Prescient Pharma, Llc Compositions and methods for treatment of short telomere disorders
US10034857B2 (en) 2015-07-02 2018-07-31 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery
WO2017087902A1 (en) 2015-11-20 2017-05-26 Forsight Vision4, Inc. Porous structures for extended release drug delivery devices
US10905682B2 (en) 2015-12-01 2021-02-02 Cornell University Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
CN108463437B (en) 2015-12-21 2022-07-08 德尔塔阀门公司 Fluid delivery system comprising a disinfection device
WO2017112452A1 (en) * 2015-12-21 2017-06-29 3M Innovative Properties Company Flow governor assemblies for use in medicinal inhalers
WO2017149122A1 (en) * 2016-03-04 2017-09-08 Morphosys Ag Clinical assessment of m-protein response in multiple myeloma
WO2017161442A1 (en) * 2016-03-24 2017-09-28 Services Medicaux Arnold Et Joan Zidulka Inc. Device and method of delivering particles in the upper respiratory tract
WO2017173458A1 (en) * 2016-04-01 2017-10-05 Swiderski Cyprianna Compositions and methods targeting hcn channels for breathing therapeutics
MX2018012021A (en) 2016-04-05 2019-01-24 Forsight Vision4 Inc Implantable ocular drug delivery devices.
US20170295843A1 (en) * 2016-04-19 2017-10-19 Leonard Storch Advanced Herb Vaporizing Prevents Burning/Singeing & Facilitates French Inhaling: Thingy™ & CozyNosie™
WO2017192660A1 (en) 2016-05-03 2017-11-09 Inova Labs, Inc. Method and systems for the delivery of oxygen enriched gas
CN109475711B (en) 2016-05-19 2022-04-15 曼金德公司 Device, system and method for detecting and monitoring inhalation
US10773049B2 (en) 2016-06-21 2020-09-15 Ventec Life Systems, Inc. Cough-assist systems with humidifier bypass
CA3026391A1 (en) * 2016-08-10 2018-02-15 Gary Stephen Shuster Vaporization improvements
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
WO2018071425A1 (en) * 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
RU174585U1 (en) * 2016-11-28 2017-10-23 Общество с ограниченной ответственностью "КсеМед" Xenon therapy device
EP3551978B1 (en) 2016-12-07 2022-01-26 Fisher&Paykel Healthcare Limited Sensing arrangements for medical devices
RU2757902C2 (en) * 2016-12-22 2021-10-22 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Therapeutic combination for the treatment of developing bpd containing pulmonary surfactant and steroid
LT3474850T (en) 2017-02-02 2020-08-10 Otolanum Ag Intranasal composition comprising betahistine
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN115444851A (en) * 2017-06-28 2022-12-09 格兰马克专业公司 Dispensing device and pharmaceutical composition for treating rhinitis
WO2019006155A1 (en) * 2017-06-28 2019-01-03 Children's Medical Center Corporation Promoting lung growth
WO2019059953A2 (en) 2017-09-22 2019-03-28 Otitopic Inc. Dry powder compositions with magnesium stearate
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
RU189311U1 (en) * 2017-10-30 2019-05-21 Ринокер Лтд Device for preparing a controlled mixture for high temperature procedures
BR112020010053A2 (en) 2017-11-21 2020-11-03 Forsight Vision4, Inc. fluid change device for expandable door release system and methods of using it
US20210113797A1 (en) * 2017-12-20 2021-04-22 Koninklijke Philips N.V. Control unit for use with a respiratory assist device
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
US20210106772A1 (en) * 2018-04-02 2021-04-15 Pneuma Respiratory, Inc. Handheld digital nebulizer device and methods of use
US11191915B2 (en) 2018-05-13 2021-12-07 Ventec Life Systems, Inc. Portable medical ventilator system using portable oxygen concentrators
KR20210124277A (en) * 2019-02-08 2021-10-14 크리스탈 바이오테크, 인크. Compositions and methods for delivering CFTR polypeptides
US20200261439A1 (en) * 2019-02-15 2020-08-20 Bn Intellectual Properties, Inc. Nicotine formulation for active mesh nebulizer
CN113993523A (en) 2019-04-17 2022-01-28 指南针探路者有限公司 Treatment of depression and other various disorders with siloxibin
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
MX2022001802A (en) * 2019-08-10 2022-03-11 Locus Ip Co Llc Methods for increasing the bioavailability of otc and pharmaceutical drugs.
CN110665097B (en) * 2019-11-27 2021-05-07 河南科技大学第一附属医院 System containing portable medical atomizer and matched disposable medicine feeder thereof
US11278688B2 (en) * 2020-03-12 2022-03-22 Max Azevedo Inhaling device for heavy metal salts and a method of use thereof for medical treatment
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
US10926209B1 (en) 2020-06-05 2021-02-23 Celios Corporation Air filtration system, air filtration device, and air filtration module for use therewith
US10870076B1 (en) 2020-06-05 2020-12-22 Celios Corporation Air filtration system, air filtration device, and air filtration module for use therewith
RU201845U1 (en) * 2020-08-04 2021-01-15 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) DEVICE OF AIR-OXYGEN-AIR MIXTURE DELIVERY CIRCUIT WITH NITROGEN OXIDE
AU2021347955A1 (en) * 2020-09-22 2023-06-01 Avalyn Pharma Inc. Nebulizer device optimization for improved aerosol parameters and uses thereof
US20220023575A1 (en) * 2020-09-29 2022-01-27 Ocean Star Promotions Inc. Breathing assist device for use in mask
RU206980U1 (en) * 2021-05-28 2021-10-05 Федеральное государственное бюджетное научное учреждение «Томский национальный исследовательский медицинский центр Российской академии наук» (Томский НИМЦ) Respiratory circuit device for artificial lung ventilation devices with the ability to deliver a gas mixture with nitrogen oxide
CN113577469B (en) * 2021-07-29 2023-04-07 徐士伟 Breathe internal medicine aerosol inhalation ware
CN113828243B (en) * 2021-09-14 2022-06-28 南京南大药业有限责任公司 Method and equipment for manufacturing nifuratel nystatin suppository
US11701479B1 (en) * 2022-02-01 2023-07-18 Green Sky Creations LLC Systems, devices, and methods for administering cannabinoid mixtures
WO2023147868A1 (en) * 2022-02-04 2023-08-10 Justus-Liebig-Universität Giessen Inhaled imatinib for treatment of pulmonary hypertension
CN115089587B (en) * 2022-08-12 2023-03-31 南京恒道医药科技股份有限公司 Compound pilocarpine composition and preparation process and application method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury
US20030084901A1 (en) * 2001-11-08 2003-05-08 Patrice Martinez Dilution regulation method and device for breathing apparatus
US20060194728A1 (en) * 2005-01-06 2006-08-31 Anthony Killian Surfactant treatment regimen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4706683A (en) * 1985-12-20 1987-11-17 Bowman Gray School Of Medicine, Wake Forest University Method and apparatus for bolus delivery of gases and aerosols and insufflations
US4989596A (en) * 1989-02-14 1991-02-05 Macris Allen G Face chamber
AU662919B2 (en) * 1991-07-02 1995-09-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US7448375B2 (en) * 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US7192553B2 (en) * 1999-12-15 2007-03-20 Plasmasol Corporation In situ sterilization and decontamination system using a non-thermal plasma discharge
DE10045586C2 (en) * 2000-09-15 2002-07-18 Alstom Power Boiler Gmbh Process and device for cleaning smoke gases containing sulfur dioxide
DE10123749A1 (en) * 2001-05-16 2002-12-12 Inamed Gmbh Aerosol delivery device
AU2002351395A1 (en) * 2001-12-17 2003-06-30 Joseph L. Mcfarland Jr. Portable, handheld, pneumatic driven medicinal nebulizer
AU2003203043A1 (en) * 2002-01-15 2003-07-30 Aerogen, Inc. Methods and systems for operating an aerosol generator
CN100482352C (en) * 2002-09-06 2009-04-29 菲利普莫里斯美国公司 Aerosol generating devices and methods for generating aerosols having controlled particle sizes
WO2005079898A2 (en) * 2004-02-20 2005-09-01 Weinmann Geräte für Medizin GmbH & Co. KG Modular device for humidifying respiratory air
US7448376B2 (en) * 2005-08-27 2008-11-11 Pamela Lepel Medication delivery device and method
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury
US20030084901A1 (en) * 2001-11-08 2003-05-08 Patrice Martinez Dilution regulation method and device for breathing apparatus
US20060194728A1 (en) * 2005-01-06 2006-08-31 Anthony Killian Surfactant treatment regimen

Also Published As

Publication number Publication date
JP2010504171A (en) 2010-02-12
US20080066739A1 (en) 2008-03-20
CA2662777A1 (en) 2008-03-27
US20080066741A1 (en) 2008-03-20
WO2008036801A2 (en) 2008-03-27
EP1902742A1 (en) 2008-03-26
EP1911481A2 (en) 2008-04-16
EP1911481A3 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
WO2008036801A3 (en) Methods and systems of delivering medication via inhalation
WO2008036798A3 (en) Methods and systems of delivering medication via inhalation
WO2008116165A3 (en) Methods and systems of delivering medication via inhalation
MX2009003048A (en) Antibody-based arrays for detecting multiple signal transducers in rare circulating cells.
WO2005102431A3 (en) Aerosol delivery apparatus for pressure assisted breathing
WO2006127257A3 (en) Patient interface assemblies for use in ventilator systems to deliver medication to a patient
MX2020013254A (en) Breath-enhanced nebulizer for delivery of aerosolized drugs to ventilated patients.
WO2011057235A3 (en) Improved delivery of submicrometer and nonometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
WO2013027078A8 (en) Aerosol delivery device
WO2012119153A3 (en) Nasal drug delivery device
WO2007037975A3 (en) System and method of administering a pharmaceutical gas to a patient
WO2006083989A3 (en) Continuous flow selective delivery of therapeutic gas
US8479728B2 (en) Effective delivery of nanoparticles and micrometer-sized pharmaceutical aerosols to the lung through enhanced condensational growth
WO2022069690A3 (en) Methods for delivery of psychedelic medications by inhalation and systems for performing the methods
WO2010037058A3 (en) Controlled inhaler for distributing inhalant according to inhalation velocity
WO2008060523A3 (en) Single nasal prong nasal cannula
WO2010091259A3 (en) Heated nebulizer devices, nebulizer systems, and methods for inhalation therapy
NZ701073A (en) Method and system for the administration of a pulmonary surfactant by atomization
WO2001074247A3 (en) Method for measuring changes in the airways of humans and other mammals
TW201420143A (en) Ventilator aerosol delivery system
MX2021012723A (en) Positive pressure inhaler for delivery of inhalable medication and methods for use.
WO2010045408A3 (en) Automated delivery of aerosolized drugs during anesthesia with synchronized ventilation
RU2012104544A (en) SYSTEM AND METHOD OF INTEGRATED APPLICATION OF RESPIRATION WITH A PRESET FREQUENCY AND INHALATION THERAPY
WO2006014167A3 (en) Face and tracheostomy nebulizing mask
WO2010070492A3 (en) Phasic respiratory therapy

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780043067.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07842863

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009529388

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2662777

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1083/KOLNP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1)EPC DATED 08-06-09

122 Ep: pct application non-entry in european phase

Ref document number: 07842863

Country of ref document: EP

Kind code of ref document: A2